We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
- Authors
Blanke, Charles D.; Rankin, Cathryn; Demetri, George D.; Ryan, Christopher W.; von Mehren, Margaret; Benjamin, Robert S.; Raymond, A. Kevin; Bramwell, Vivien H.C.; Baker, Laurence H.; Maki, Robert G.; Tanaka, Michael; Hecht, J. Randolph; Heinrich, Michael C.; Fletcher, Christopher D.M.; Crowley, John J.; Borden, Ernest C.
- Publication
Journal of Clinical Oncology, 2008, Vol 26, Issue 4, p626
- ISSN
0732-183x
- Publication type
article
- DOI
10.1200/jco.2007.13.4452